First National Trust’s iShares Biotechnology ETF IBB Stock Holding History

First National Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,021	Closed	-$246K	–	323
2018 Q3	$246K	Hold	2,021	–	–	0.03%	299
2018 Q2	$222K	Sell	2,021 -530	-21%	-$56.7K	0.02%	305
2018 Q1	$272K	Sell	2,551 -120	-4%	-$13.3K	0.03%	292
2017 Q4	$285K	Sell	2,671 -707	-21%	-$75.6K	0.03%	291
2017 Q3	$376K	Sell	3,378 -12	-0.4%	-$1.28K	0.04%	260
2017 Q2	$350K	Buy	3,390 +1,155	+52%	+$114K	0.04%	262
2017 Q1	$218K	Buy	+2,235	New	+$214K	0.03%	301

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

First National Trust's IBB Position: Q4 2018 in Review

First National Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 2,021 shares — an estimated $246K sold.

First National Trust first reported a position in IBB in Q1 2017 and held it in 7 quarters. The position peaked at $376K in Q3 2017. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

First National Trust reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
First National Trust sold 2,021 iShares Biotechnology ETF shares in Q4 2018, an estimated $246K.
First National Trust first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 7 quarters.
First National Trust's iShares Biotechnology ETF position peaked at $376K in Q3 2017.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on First National Trust's 13F filing for Q4 2018, filed 28 Jan 2019.